PP
SLDB icon

PDT Partners’s Solid Biosciences SLDB Stock Holding History

PDT Partners’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,747
Closed -$84K – 846
2020
Q3 		$84K Sell
2,747
-140
-5% -$5.36K 0.01% 686
2020
Q2 		$127K Sell
2,887
-3,912
-58% -$162K 0.01% 621
2020
Q1 		$244K Sell
6,799
-1,180
-15% -$58.4K 0.02% 517
2019
Q4 		$533K Buy
7,979
+3,919
+97% +$432K 0.03% 404
2019
Q3 		$630K Sell
4,060
-3,493
-46% -$395K 0.04% 321
2019
Q2 		$651K Buy
+7,553
New +$824K 0.04% 285

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

PDT Partners's SLDB Position: Q4 2020 in Review

PDT Partners sold out of Solid Biosciences (SLDB) in Q4 2020, closing a stake of 2,747 shares — an estimated $84K sold.

PDT Partners first reported a position in SLDB in Q2 2019 and held it in 6 quarters. The position peaked at $651K in Q2 2019. 75 funds tracked by Wall St. Rank hold SLDB as of Q4 2020.

  • PDT Partners reported no remaining Solid Biosciences position as of Q4 2020 after selling out during the quarter.
  • PDT Partners sold 2,747 Solid Biosciences shares in Q4 2020, an estimated $84K.
  • PDT Partners first reported a position in Solid Biosciences in Q2 2019 and held it in 6 quarters.
  • PDT Partners's Solid Biosciences position peaked at $651K in Q2 2019.
  • 75 funds tracked by Wall St. Rank held Solid Biosciences as of Q4 2020.

Based on PDT Partners's 13F filing for Q4 2020, filed 16 Feb 2021.